Biogen Reaches Settlement and License Agreement for MS Drug
Biogen has reached a settlement and license agreement with Forward Pharma for its best-selling multiple sclerosis drug ahead of the completion of a patent-interference case.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news
More News: Multiple Sclerosis | Pharmaceuticals